title: Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism.
authors.forename: Masaki
authors.initials: M
authors.lastname: Kato
authors.forename: Naoya
authors.initials: N
authors.lastname: Shimohashi
authors.forename: Jiro
authors.initials: J
authors.lastname: Ouchi
authors.forename: Kisaku
authors.initials: K
authors.lastname: Yoshida
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Tanabe
authors.forename: Kenji
authors.initials: K
authors.lastname: Takenaka
authors.forename: Makoto
authors.initials: M
authors.lastname: Nakamuta
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001772:Blood Cell Count; D004621:Embolization, Therapeutic; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy*; D006801:Humans; D006971:Hypersplenism / Q000150:complications / Q000628:therapy*; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013157:Splenic Artery
chemical_list: D000998:Antiviral Agents; D007155:Immunologic Factors; D016898:Interferon-alpha